115 results
Page 2 of 6
8-K
EX-99.1
dgx17nd
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
EX-3.1
t0ui5qlhj32 btu
2 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:14pm
8-K
EX-99.1
h4fal5m
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.2
503no c0olrf5yera
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.1
58feu15 c7xh4jbqos6i
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
EX-99.2
i4fx6ly 1toyqkny9
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
EX-99.1
8r7yvklgoz d9
18 May 22
Passage Bio Presents New Interim Clinical and Biomarker
7:16am
8-K
EX-99.2
te4hvcnsyr9o8e
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.1
es8bi26hf4 r0gh
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
POS AM
6s2xfy7
3 Mar 22
Prospectus update (post-effective amendment)
8:29am
8-K
EX-99.1
bgv8lj1
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am